Back to Investors
N

Nomura

Venture Capital

Portfolio

2

companies


Portfolio companies

Fnality

Fnality

Fnality operates regulated wholesale payment systems using distributed ledger technology.

Huma Therapeutics

Huma Therapeutics

Huma Therapeutics develops a modular digital health platform for virtual hospital care and decentralized clinical trials.


Recent investments

Series B
£77.7M

The financing round will support the launch of wholesale payment systems and global liquidity management.

"Our Series B funding round represents the financial sector’s desire for a central bank money backed blockchain-based settlement solution that bridges the gap between traditional finance (TradFi) and decentralised finance (DeFi) in wholesale markets. Each Fnality Payment System utilises DLT to provide a 24/7 payment rail with the ability to reduce settlement cycles to real-time, while significantly improving intraday liquidity management and marking significant innovation in the speed, functionality, and resilience of wholesale payments."
— Rhomaios Ram, CEO
Series C
$130M

The Series C financing was led by Leaps by Bayer and Hitachi Ventures to support international expansion and platform development.

"This is a pivotal moment in Huma’s development. We have exceptional partners and strategic investors who will support us in our mission to help people worldwide live longer and fuller lives. We’re already demonstrating how ‘hospital at home’ can transform healthcare, and how decentralized clinical trials can advance research in ways that weren’t imaginable even one year ago. Now we want to accelerate the pace of change and continue to innovate for better care and research worldwide."
— Dan Vahdat